2022
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk J, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern D, Melmed G, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai P, Boland B, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn W, Singh S. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. The American Journal Of Gastroenterology 2022, 117: 1639-1647. PMID: 35973139, DOI: 10.14309/ajg.0000000000001855.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseBiologic-treated patientsRisk of hospitalizationBody mass indexNormal body mass indexSerious infectionsBiologic agentsBowel diseaseCox proportional hazards analysisWorld Health Organization classificationEffect of obesityProportional hazards analysisElectronic health recordsCause hospitalizationVisceral obesityAdult patientsBaseline demographicsBiologic initiationBiologic therapyCohort studyEndoscopic outcomesMass indexOrganization classificationTreatment characteristicsStratified analysis
2003
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
Resnic F, Wainstein M, Lee M, Behrendt D, Wainstein R, Ohno-Machado L, Kirshenbaum J, Rogers C, Popma J, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. American Heart Journal 2003, 145: 42-46. PMID: 12514653, DOI: 10.1067/mhj.2003.36.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionPostprocedural myocardial infarctionStrong independent predictorMyocardial infarctionIndependent predictorsSodium nitroprussideInhospital outcomesCoronary interventionClinical outcomesSaphenous vein graft interventionIntracoronary vasodilator therapyVein graft interventionAdministration of verapamilAcute myocardial infarctionRate of deathInhospital mortalityVasodilator therapyCardiogenic shockBaseline demographicsGraft interventionUnstable anginaAdverse eventsConsecutive patientsIntracoronary verapamilInfarction